Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy

Chronic hepatitis B virus (HBV) infection remains a substantial public health burden worldwide. Alpha-interferon (IFNα) is one of the two currently approved therapies for chronic hepatitis B (CHB), to explore the mechanisms underlying IFNα treatment response, we investigated baseline and 24-week on-...

Full description

Bibliographic Details
Main Authors: Ning Li, Kangkang Yu, Minhui Dong, Jinyu Wang, Feifei Yang, Haoxiang Zhu, Jie Yu, Jingshu Yang, Wentao Xie, Bidisha Mitra, Richeng Mao, Feizhen Wu, Haitao Guo, Jiming Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
Chronic hepatitis B
interferon therapy
liver biopsy
transcriptome
HBeAg
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2100831

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2100831

Similar Items